Drugs / Aventis Pasteur Smallpox Vaccine
Aventis Pasteur Smallpox Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00050518 | ? → Feb 2003 | smallpox | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Aventis Pasteur Smallpox Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00050518 ↗ |
| Known as | APSV | “A Multicenter, Double-Blind, Randomized Study of the Safety and Efficacy of Aventis Pasteur's Smallpox Vaccine, USP (APSV) in Vaccinia-Naive Adults.” NCT00050518 ↗ |
| Known as | Aventis Pasteur's Smallpox Vaccine, USP | “A Multicenter, Double-Blind, Randomized Study of the Safety and Efficacy of Aventis Pasteur's Smallpox Vaccine, USP (APSV) in Vaccinia-Naive Adults.” NCT00050518 ↗ |
| Modality | Vaccine | “Aventis Pasteur's Smallpox Vaccine, USP (APSV)” NCT00050518 ↗ |